Chronic daily administration of selegiline and EGb 761 increases brain's resistance to ischemia in mice.
D000199:Actins / Q000737:chemistry; D000818:Animals; D017209:Apoptosis; D001921:Brain / Q000187:drug effects* / Q000502:physiology*; D002545:Brain Ischemia / Q000517:prevention & control*; D020169:Caspases / Q000502:physiology; D002544:Cerebral Infarction / Q000473:pathology; D004334:Drug Administration Schedule; D020441:Ginkgo biloba; D007113:Immunity, Innate; D020287:In Situ Nick-End Labeling; D051379:Mice; D009474:Neurons / Q000378:metabolism / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010936:Plant Extracts / Q000008:administration & dosage* / Q000494:pharmacology; D012642:Selegiline / Q000008:administration & dosage* / Q000494:pharmacology*; D000096983:Ginkgo Extract